Home Infusion Therapy Market Size

Home Infusion Therapy Market Size

Home Infusion Therapy Market size was valued at USD 31.9 billion in 2023 and is expected to exhibit growth at a CAGR of 11% from 2024 to 2032. High market growth can be attributed to ongoing advancements in infusion technology, the rising prevalence of chronic diseases, favorable reimbursement policies, and increasing patient preference for home-based care, among other contributing factors.

To get key market trends

  Download Free Sample

Moreover, chronic diseases such as diabetes, cancer, and cardiovascular conditions are on the rise globally. For instance, as per the data reported by Centers for Disease Control and Prevention (CDC), around 805,000 people suffer from heart attack every year in the U.S. Additionally, 1 in every 5 persons in the U.S. or around 695,000 people died from heart diseases in 2021. Therefore, these conditions often require long-term treatment and management, which can be effectively provided through home infusion therapy. The convenience and comfort of receiving therapy at home, without frequent hospital visits, significantly enhance patient adherence and outcomes.
 

Furthermore, home infusion therapy is often more cost-effective compared to inpatient care. It reduces hospital stay durations and associated healthcare costs, including bed occupancy and healthcare worker time. This cost-efficiency is appealing to both healthcare systems and patients, driving the market growth.
 

Home infusion therapy involves the administration of medications and biologicals intravenously or through other non-oral routes, such as subcutaneously, in a patient’s home. This therapy is designed to treat a wide range of medical conditions, including infections, dehydration, gastrointestinal diseases, and chronic diseases requiring long-term drug administration.